Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience

07/ 28/ 2017

Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, Marco Corigliano, Emilia Martedi, Domenica Oliva, Antonietta Santorelli, Rosa Simonetti, Armando Giammarco, Caterina Colella, Luigia Miretto, Alessandra D’Alessandro, Viviana Russo, Giuseppina Guarino, Giampiero Marino, Gerardo Corigliano, Felice Strollo and Sandro Gentile*

LATEST ARTICLES

tag45

2023 Aug

National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

doi. 10.17140/CSMMOJ-7-133

2023 Jun

Testing Post 3

Irina Angel

doi. 10.17140/CSMMOJ-7

2023 Jun

Testing Post 2

Irina Angel

doi. Testing Post

Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience

LATEST ARTICLES

2023 Aug

National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

2023 Jun

Testing Post 3

2023 Jun

Testing Post 2

company

Open Journals

Open discoveriEs

Open communities

others